GNG5 and central nervous system cancer: Furthermore, IHC staining results based on clinical samples showed that the expression level of GNG5 in gliomas was significantly higher than that in control groups and higher in high-grade gliomas than in low-grade gliomas (Fig. 1e), and this result was also confirmed in the HPA database (Additional file 4: Figure S1A).